Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H3NO3 |
| Molecular Weight | 113.0715 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+](=O)C1=CC=CO1
InChI
InChIKey=FUBFWTUFPGFHOJ-UHFFFAOYSA-N
InChI=1S/C4H3NO3/c6-5(7)4-2-1-3-8-4/h1-3H
| Molecular Formula | C4H3NO3 |
| Molecular Weight | 113.0715 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| 2,3-Dibromo-1-(4-methyl-phen-yl)-3-(5-nitro-furan-2-yl)propan-1-one. | 2010-12-11 |
|
| 2,3-Dibromo-1-(4-chloro-phen-yl)-3-(5-nitro-2-fur-yl)propan-1-one. | 2010-11-20 |
|
| 2,3-Dibromo-3-(5-nitro-2-fur-yl)-1-(4-nitro-phen-yl)propan-1-one. | 2010-11-13 |
|
| 3-(5-Nitro-2-fur-yl)-1-phenyl-prop-2-yn-1-one. | 2010-10-31 |
|
| Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine. | 2010-09 |
|
| (4-Chloro-phen-yl)[1-(4-methoxy-phen-yl)-3-(5-nitro-2-fur-yl)-1H-pyrazol-4-yl]methanone. | 2010-04-14 |
|
| Synthesis and antiproliferative evaluations of certain 2-phenylvinylquinoline (2-styrylquinoline) and 2-furanylvinylquinoline derivatives. | 2010-01-01 |
|
| Effect of ruthenium complexation on trypanocidal activity of 5-nitrofuryl containing thiosemicarbazones. | 2009-12 |
|
| Use of nfsB, encoding nitroreductase, as a reporter gene to determine the mutational spectrum of spontaneous mutations in Neisseria gonorrhoeae. | 2009-11-23 |
|
| (4-Methyl-phen-yl)[3-(5-nitro-2-fur-yl)-1-phenyl-1H-pyrazol-4-yl]methanone. | 2009-11-14 |
|
| 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies. | 2009-10 |
|
| E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954. | 2009-06-16 |
|
| Genetic architecture of intrinsic antibiotic susceptibility. | 2009-05-20 |
|
| 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species. | 2009-02-15 |
|
| Preliminary evaluation of the toxicity of some synthetic furan derivatives in two cell lines and Artemia salina. | 2009-01 |
|
| Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole. | 2009 |
|
| Synthesis, spectroscopic, and antimicrobial studies on bivalent zinc and mercury complexes of 2-formylpyridine thiosemicarbazone. | 2009 |
|
| ESR, electrochemical and reactivity studies of antitrypanosomal palladium thiosemicarbazone complexes. | 2008-08 |
|
| Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines. | 2008-04-15 |
|
| Thiosemicarbazones active against Clostridium difficile. | 2008-03-01 |
|
| Insight into the bioreductive mode of action of antitrypanosomal 5-nitrofuryl containing thiosemicarbazones. | 2008-01 |
|
| Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents. | 2007-12-05 |
|
| Thanatop: a novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase II. | 2007-05-01 |
|
| Trypanothione reductase: a viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design. | 2007 |
|
| Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of Nifurtimox, an antitrypanosomiasis drug. | 2006-07 |
|
| New potent 5-nitrofuryl derivatives as inhibitors of Trypanosoma cruzi growth. 3D-QSAR (CoMFA) studies. | 2006-04 |
|
| Conformational analyses and docking studies of a series of 5-nitrofuran- and 5-nitrothiophen-semicarbazone derivatives in three possible binding sites of trypanothione and glutathione reductases. | 2006-03 |
|
| In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones. | 2004-09-15 |
|
| Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design. | 2004-05 |
|
| Analysis of 5-nitrofuran derivatives in biological objects. | 2003-01 |
|
| Investigation of 5-nitrofuran derivatives: synthesis, antibacterial activity, and quantitative structure-activity relationships. | 2001-10-25 |
|
| Cytogenetic analysis of children under long-term antibacterial therapy with nitroheterocyclic compound furagin. | 2001-04-05 |
|
| Synthesis and antibacterial activity of 5-nitrofuryl and 3-methoxy-2-nitrophenyl derivatives of 6 beta-aminopenicillanic, 7 beta-aminocephalosporanic and 7 beta-aminodesacetoxy-cephalosporanic acids. | 2001 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:05:23 GMT 2025
by
admin
on
Mon Mar 31 19:05:23 GMT 2025
|
| Record UNII |
17EZI4D981
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80870682
Created by
admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
|
PRIMARY | |||
|
17EZI4D981
Created by
admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
|
PRIMARY | |||
|
34890
Created by
admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
|
PRIMARY | |||
|
59983
Created by
admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
|
PRIMARY | |||
|
100000176578
Created by
admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
|
PRIMARY | |||
|
609-39-2
Created by
admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
|
PRIMARY | |||
|
11865
Created by
admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
|
PRIMARY |